Clinical Trial Update: A Trial of SHR1258 in Patients With Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of SHR1258 for biliary tract cancer has been withdrawn by the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• SHR1258

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Biliary Tract Cancer | Phase 2 | Status: WITHDRAWN